Jian Chen is the lead sponsor of 5 current clinical trials in our China register. 5 are recruiting patients now. All registered phases are Phase 2. The most-studied condition is Non-small Cell Lung Cancer.
| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Clinical Study of Carbon Ion Radiotherapy Combined With Chemotherapy for Thymic Epithelial Tumors
NCT06186726 · Carbon Ion Radiotherapy, Thymoma, Thymic Carcinoma, Radiotherapy, Chemotherapy
|
Phase 2 | Recruiting | 2024-01 | China |
|
Randomized Study of Carbon Ion Boost in Hypoxic Lesions for Locally Advanced Non-small Cell Lung Cancer
NCT06205927 · ClinicalTrials.gov ↗ · Non-small Cell Lung Cancer
|
Phase 2 | Recruiting | 2023-12 | China |
|
Carbon Ion Radiotherapy for Locally Advanced Lung Cancer in Elderly Patients
NCT06311981 · ClinicalTrials.gov ↗ · Non-small Cell Lung Cancer, Older People, Carbon Ion Radiotherapy
|
Phase 2 | Recruiting | 2024-08 | China |
|
Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymus Tumor With Residual Tumor
NCT06311955 · ClinicalTrials.gov ↗ · Thymic Epithelial Tumor, Radiotherapy Side Effect, Carbon Ion Radiotheray
|
Phase 2 | Recruiting | 2025-07 | China |
|
The Clinical Study of Post-operative Proton Radiotherapy for Thymus Tumor
NCT06311968 · ClinicalTrials.gov ↗ · Thymus Epithelial Tumor, Proton Radiotherapy, Radiation Toxicity
|
Phase 2 | Recruiting | 2024-05 | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 5 | 5 |
A trial with sites in more than one country appears in each of those registers.
Sponsors with the most current trials registered for this condition.
Jian Chen is the lead sponsor of 5 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 5 of its 5 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.